Not intended for diagnostic, therapeutic, or clinical use
2 Tirzepatide Proves Cardiovascular Superiority (SURPASS-CVOT) Presented at #ACC26, a head-to-head analysis against the mono-agonist dulaglutide showed that tirzepatide was associated with a 16% lower risk of a composite cardiorenal endpoint (heart attack, stroke, death, and kidney failure)
-0.3) at the 6-month follow-up and by -0.8 kg/m 2 (95% CI: -1.1
18 With continued efforts in the development of newer antidiabetic agents, unimolecular GLP1R/GIPR dual agonists (twincretins) can provide added efficacy, especially among obese individuals with T2DM
Ingredients like Centella asiatica and chamomile extract help boost collagen production , improve skin elasticity , and reduce the appearance of cellulite